FDA Push to Ban Bioidenticals Moving Forward
An update on efforts to preserve access to bioidentical hormone replacement therapy. Action Alert! We’ve been telling you about the FDA’s efforts to curtail or eliminate patient access to bioidentical hormones, as well as potential intellectual property challenges from the pharmaceutical industry that would prevent compounding pharmacies from preparing these important medicines. We’re happy to […]








